An attempt to revise the system of coverage of drug costs from the public coffers led to an open conflict involving the Health Ministry, economic analysts and pharmaceutical companies that has left patients caught in the middle. Anca Dragu reports.
Drug prices
Máte problém s prehrávaním? Nahláste nám chybu v prehrávači.
Anca Dragu, Photo: Flickr.com/Gary H
